BG61121B1 - Съединения,производни на индана,метод за получаване и междинни продукти при получаването,тяхното приложение като лекарствени средства и съдържащите ги фармацевтични състави - Google Patents

Съединения,производни на индана,метод за получаване и междинни продукти при получаването,тяхното приложение като лекарствени средства и съдържащите ги фармацевтични състави

Info

Publication number
BG61121B1
BG61121B1 BG098525A BG9852594A BG61121B1 BG 61121 B1 BG61121 B1 BG 61121B1 BG 098525 A BG098525 A BG 098525A BG 9852594 A BG9852594 A BG 9852594A BG 61121 B1 BG61121 B1 BG 61121B1
Authority
BG
Bulgaria
Prior art keywords
carbon atoms
group
hydrogen atom
atom
alkyl radical
Prior art date
Application number
BG098525A
Other languages
English (en)
Other versions
BG61121B2 (bg
Inventor
Francois Clemence
Michel Fortin
Gilles Hamon
Odile Martret
Anne-Marie Moura
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR888816605A external-priority patent/FR2640625B2/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of BG61121B1 publication Critical patent/BG61121B1/bg
Publication of BG61121B2 publication Critical patent/BG61121B2/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Изобретението се отнася до съединения с формула в която r1 и r2, еднакви или различни, означават водороден атом или алкилов радикал, съдържащ от 1 до 5 въглеродни атома, или r1 и r2 образуват заедно с въглеродния атом, до който са свързани, циклоалкил, съдържащ между 3 и 6 въглеродни атома, и могат да съдържат евентуално хетероатом като кислороден, серен или азотен; и r6 и r7, еднакви или различни, означават халогенен атом, алкилов радикал или алкокси, съдържащ от 1 до 5 въглеродни атома, а и в са такива, че един от тях е от групата с формула в която r означава водороден атом или алкилна група с 1 до 5 въглеродни атома; z е линейна алкиленова верига-(сн2)n; n е число, което може да се изменя от 0 до 5, или разклонена алкиленова верига с 2 до 8 въглеродни атома или групата -сн2-0, х, х' и х'', еднакви или различни, означават водороден атом, алкилов радикал или алкокси, съдържащ от 1 до 4 въглеродни атома, халогенен атом, хидроксилов радикал, трифлуорметил, нитро, амино, моноалкил или диалкиламино или сулфоаминова група, а другите от субституентите а или в са избрани от групата с формулав която r3 и r4, еднакви или различни, означават водороден атом или алкилов радикал с 1 до 5 въглеродни атома или r3 и r4 образуват заедно с азотния атом, към който са свързани, хетероцикъл с 5 или 6 звена, който в дадения случай съдържа друг хетероатом като кислород, азот или сяра, при което азотният атом е заместен евентуално с алкилов радикал с 1 до 4 въглеродни атома; или r6 и r7 означават водороден атом; или в означава пиролидинов радикал и а означава групата 3,5-бис-(1,1-диметилетил)-4-хидрокси-n-метилбензамид, n-метил-3-нитробензолацетамид, или 3,4-дихлор-n-метилбензолацетамид, при което последните два продукта при необходимост могат да бъдат под формата на енантиомери; или а означава радикал 3,4-дихлор-n-метилбензолацетамид, и в означава метил-(2-фенилетил)-аминогрупа или (2-фурилметил)-метиламиногрупа или 4-(2-метоксифен
BG98525A 1988-12-16 1994-02-23 Съединения,производни на индана,метод за получаване и междинни продукти при получаването,тяхното приложение като лекарствени средства и съдържащите ги фармацевтични състави BG61121B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR888816605A FR2640625B2 (fr) 1986-08-21 1988-12-16 Nouveaux composes optiquement actifs derives de l'indane, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
BG61121B1 true BG61121B1 (bg) 1996-11-29
BG61121B2 BG61121B2 (bg) 1996-11-29

Family

ID=9373020

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98525A BG61121B2 (bg) 1988-12-16 1994-02-23 Съединения,производни на индана,метод за получаване и междинни продукти при получаването,тяхното приложение като лекарствени средства и съдържащите ги фармацевтични състави

Country Status (13)

Country Link
US (1) US5436244A (bg)
EP (1) EP0374054B1 (bg)
JP (1) JP2753591B2 (bg)
AT (1) ATE95517T1 (bg)
AU (1) AU630136B2 (bg)
BG (1) BG61121B2 (bg)
CA (1) CA2005626A1 (bg)
DE (1) DE68909757T2 (bg)
DK (1) DK626889A (bg)
ES (1) ES2059805T3 (bg)
HU (2) HU219446B (bg)
IE (1) IE65151B1 (bg)
ZA (1) ZA899616B (bg)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
DE19929076A1 (de) 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
AU2016258192B2 (en) 2015-05-06 2021-07-29 Leidos Biomedical Research, Inc. K-Ras modulators
GB201601301D0 (en) * 2016-01-25 2016-03-09 Takeda Pharmaceutical Novel compounds
WO2018195439A2 (en) 2017-04-20 2018-10-25 The Regents Of The University Of California K-ras modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1109080A (en) * 1978-05-30 1981-09-15 Hideo Kato Indanamine derivatives
US4359476A (en) * 1981-04-09 1982-11-16 The Upjohn Company Adjacently substituted cycloalkane-amide analgesics
US4460600A (en) * 1981-04-09 1984-07-17 The Upjohn Company Adjacently substituted ketal derivatives of cycloalkane-amide analgesics
US4466977A (en) * 1981-04-09 1984-08-21 The Upjohn Company N-[2-Amino(oxy- or thia- group-substituted-cycloaliphatic)]benzeneacetamides and -benzamide analgesics
US4360531A (en) * 1981-04-09 1982-11-23 The Upjohn Company Substituted cycloalkanes
GB2096607B (en) * 1981-04-09 1985-02-27 Upjohn Co Aminocycloalkyl amides
DE3781627T2 (de) * 1986-08-21 1993-05-06 Roussel Uclaf Indanderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, diese enthaltende pharmazeutische zusammensetzungen und erhaltene zwischenprodukte.
US4876269A (en) * 1986-09-10 1989-10-24 E. I. Du Pont De Nemours And Company Benoz-fused cycloalkane trans-1,2-diamine derivatives
FR2608598B1 (fr) * 1986-12-23 1989-04-14 Roussel Uclaf Nouveaux derives de l'indane, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant

Also Published As

Publication number Publication date
EP0374054A1 (fr) 1990-06-20
DE68909757D1 (de) 1993-11-11
IE65151B1 (en) 1995-10-04
CA2005626A1 (fr) 1990-06-16
BG61121B2 (bg) 1996-11-29
DE68909757T2 (de) 1994-03-31
IE894027L (en) 1990-06-16
HU896631D0 (en) 1990-02-28
DK626889D0 (da) 1989-12-12
EP0374054B1 (fr) 1993-10-06
ATE95517T1 (de) 1993-10-15
US5436244A (en) 1995-07-25
AU630136B2 (en) 1992-10-22
HU219446B (hu) 2001-04-28
AU4680289A (en) 1990-06-21
HUT53094A (en) 1990-09-28
HU211609A9 (en) 1995-12-28
JP2753591B2 (ja) 1998-05-20
ZA899616B (en) 1991-02-27
JPH02218653A (ja) 1990-08-31
ES2059805T3 (es) 1994-11-16
DK626889A (da) 1990-06-17

Similar Documents

Publication Publication Date Title
ES2102478T3 (es) Complejos de vanadio, su preparacion y composiciones farmaceuticas que los contienen.
ATE40122T1 (de) N-(2-nitrophenyl)-2-aminopyrimidin-derivate, deren herstellung und verwendung.
TR200002671T2 (tr) Bisiklo(2.2.1)Heptanlar ve ilgili bileşikler
ES544463A0 (es) Procedimiento para la preparacion de derivados de n-(2-ni- trofenil)-2-aminopirimidina
ATE16805T1 (de) Trifluoromethylphenyltetrahydropyridine mit appetithemmender wirkung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE277049T1 (de) Substituierte aminoalkylverbindungen
KR880007085A (ko) 고지질혈증 치료용의 약학 조성물
BG61121B1 (bg) Съединения,производни на индана,метод за получаване и междинни продукти при получаването,тяхното приложение като лекарствени средства и съдържащите ги фармацевтични състави
YU38399A (sh) Supstituisani derivati 1,3-bis(cikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il)fenila,njihovo dobijanje i upotreba za proizvodnju medikamenata za lečenje inflamatornih stanja i imuno poremećaja
DE3778508D1 (de) Substituierte triazinderivate.
FR2713085B1 (fr) Composition tinctoriale contenant des p-phénylènediamines soufrées et procédés de teinture correspondants, nouvelles p-phénylènediamines soufrées et leur procédé de préparation.
ES8205756A1 (es) Procedimiento de preparacion de una composicion cosmetica destinada a ser utilizada para el tratamiento de materias queratinicas
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
SE8303913D0 (sv) Heterocykliska foreningar
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
IL74324A (en) 3-phenyl-2-propeneamine derivatives,their preparation and pharmaceutical compositions containing them
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
PT90815A (pt) Processo de preparacao de derivados da fenotiazina
DE3865656D1 (de) Trizyklische derivate, agonistn von cholinergetischen rezeptoren und diese enthaltende arzneimittel.
DK0434560T3 (da) Hidtil ukendte substituerede aminosyrederivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
GB1317598A (en) Pesticidal adducts of thiophosphorus acids and n-vinyl compounds and process of preparing same
FR2603035A1 (fr) Nouveaux derives de l'indane, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
KR890014483A (ko) 치환 벤젠 유도체, 그의 제조방법 및 이 화합물을 함유하는 항암성 조성물